BIO-B vs BRKR
Bio-Rad Laboratories, Inc. Class B Common Stock · Bruker Corporation - Common Stock
Relative return (rebased to 100)
Key stats
| Metric | BIO-B | BRKR |
|---|---|---|
| Price | $337.00 | $57.93 |
| Market Cap | $9.32B | $8.82B |
| P/E | 12.27 | — |
| P/B | 1.36 | 3.57 |
| P/S | 3.61 | 2.57 |
| ROE | 11.1% | -0.3% |
| Net Margin | 29.4% | -0.3% |
| Gross Margin | 51.9% | 45.9% |
| Revenue Growth | 0.7% | 2.1% |
| Dividend Yield | — | 0.35% |
| EPS | $27.46 | -$0.06 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.